nodes	percent_of_prediction	percent_of_DWPC	metapath
Testosterone Propionate—AR—scrotum—skin cancer	0.0688	0.304	CbGeAlD
Testosterone Propionate—AR—penis—skin cancer	0.031	0.137	CbGeAlD
Testosterone Propionate—COMT—hair follicle—skin cancer	0.0163	0.0721	CbGeAlD
Testosterone Propionate—COMT—nipple—skin cancer	0.0111	0.0489	CbGeAlD
Testosterone Propionate—CYP17A1—connective tissue—skin cancer	0.0107	0.0474	CbGeAlD
Testosterone Propionate—AR—nipple—skin cancer	0.00809	0.0358	CbGeAlD
Testosterone Propionate—CYP17A1—female reproductive system—skin cancer	0.00756	0.0334	CbGeAlD
Testosterone Propionate—COMT—skin of body—skin cancer	0.00708	0.0313	CbGeAlD
Testosterone Propionate—COMT—mammalian vulva—skin cancer	0.00645	0.0285	CbGeAlD
Testosterone Propionate—CYP17A1—head—skin cancer	0.00632	0.0279	CbGeAlD
Testosterone Propionate—AR—connective tissue—skin cancer	0.00574	0.0254	CbGeAlD
Testosterone Propionate—COMT—female reproductive system—skin cancer	0.00553	0.0244	CbGeAlD
Testosterone Propionate—AR—epithelium—skin cancer	0.00545	0.0241	CbGeAlD
Testosterone Propionate—AR—skin of body—skin cancer	0.00518	0.0229	CbGeAlD
Testosterone Propionate—AR—mammalian vulva—skin cancer	0.00472	0.0209	CbGeAlD
Testosterone Propionate—COMT—head—skin cancer	0.00462	0.0204	CbGeAlD
Testosterone Propionate—CYP17A1—lymph node—skin cancer	0.00442	0.0195	CbGeAlD
Testosterone Propionate—AR—lymphoid tissue—skin cancer	0.00419	0.0185	CbGeAlD
Testosterone Propionate—AR—female reproductive system—skin cancer	0.00405	0.0179	CbGeAlD
Testosterone Propionate—Connective tissue disorder—Vemurafenib—skin cancer	0.00371	0.0048	CcSEcCtD
Testosterone Propionate—Erectile dysfunction—Imiquimod—skin cancer	0.00371	0.00479	CcSEcCtD
Testosterone Propionate—Inflammation—Fluorouracil—skin cancer	0.00365	0.00472	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Vismodegib—skin cancer	0.00355	0.00459	CcSEcCtD
Testosterone Propionate—Neoplasm—Temozolomide—skin cancer	0.00348	0.00449	CcSEcCtD
Testosterone Propionate—Abdominal pain—Vismodegib—skin cancer	0.00344	0.00444	CcSEcCtD
Testosterone Propionate—Angiopathy—Vemurafenib—skin cancer	0.00343	0.00443	CcSEcCtD
Testosterone Propionate—Mediastinal disorder—Vemurafenib—skin cancer	0.00341	0.0044	CcSEcCtD
Testosterone Propionate—Hepatobiliary disease—Imiquimod—skin cancer	0.0034	0.00439	CcSEcCtD
Testosterone Propionate—AR—head—skin cancer	0.00338	0.0149	CbGeAlD
Testosterone Propionate—Alopecia—Vemurafenib—skin cancer	0.00334	0.00432	CcSEcCtD
Testosterone Propionate—Malnutrition—Vemurafenib—skin cancer	0.00329	0.00425	CcSEcCtD
Testosterone Propionate—Haemoglobin—Imiquimod—skin cancer	0.00324	0.00419	CcSEcCtD
Testosterone Propionate—COMT—lymph node—skin cancer	0.00323	0.0143	CbGeAlD
Testosterone Propionate—Haemorrhage—Imiquimod—skin cancer	0.00322	0.00417	CcSEcCtD
Testosterone Propionate—Urinary tract disorder—Imiquimod—skin cancer	0.00318	0.00411	CcSEcCtD
Testosterone Propionate—Connective tissue disorder—Imiquimod—skin cancer	0.00317	0.00409	CcSEcCtD
Testosterone Propionate—Urethral disorder—Imiquimod—skin cancer	0.00316	0.00408	CcSEcCtD
Testosterone Propionate—Asthenia—Vismodegib—skin cancer	0.00312	0.00403	CcSEcCtD
Testosterone Propionate—Pruritus—Vismodegib—skin cancer	0.00307	0.00397	CcSEcCtD
Testosterone Propionate—Diarrhoea—Vismodegib—skin cancer	0.00297	0.00384	CcSEcCtD
Testosterone Propionate—Angiopathy—Imiquimod—skin cancer	0.00292	0.00378	CcSEcCtD
Testosterone Propionate—Immune system disorder—Imiquimod—skin cancer	0.00291	0.00376	CcSEcCtD
Testosterone Propionate—Mediastinal disorder—Imiquimod—skin cancer	0.0029	0.00375	CcSEcCtD
Testosterone Propionate—Liver function test abnormal—Dactinomycin—skin cancer	0.00285	0.00368	CcSEcCtD
Testosterone Propionate—Alopecia—Imiquimod—skin cancer	0.00285	0.00368	CcSEcCtD
Testosterone Propionate—Mental disorder—Imiquimod—skin cancer	0.00282	0.00365	CcSEcCtD
Testosterone Propionate—Malnutrition—Imiquimod—skin cancer	0.00281	0.00363	CcSEcCtD
Testosterone Propionate—Myalgia—Vemurafenib—skin cancer	0.0028	0.00362	CcSEcCtD
Testosterone Propionate—Arthralgia—Vemurafenib—skin cancer	0.0028	0.00362	CcSEcCtD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—skin cancer	0.00278	0.00359	CcSEcCtD
Testosterone Propionate—Vomiting—Vismodegib—skin cancer	0.00276	0.00357	CcSEcCtD
Testosterone Propionate—Rash—Vismodegib—skin cancer	0.00274	0.00354	CcSEcCtD
Testosterone Propionate—Dermatitis—Vismodegib—skin cancer	0.00274	0.00354	CcSEcCtD
Testosterone Propionate—Dermatitis bullous—Fluorouracil—skin cancer	0.00269	0.00348	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Vemurafenib—skin cancer	0.00269	0.00347	CcSEcCtD
Testosterone Propionate—Inflammation—Docetaxel—skin cancer	0.00264	0.00341	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Vemurafenib—skin cancer	0.00263	0.0034	CcSEcCtD
Testosterone Propionate—Skin disorder—Vemurafenib—skin cancer	0.00261	0.00337	CcSEcCtD
Testosterone Propionate—Ill-defined disorder—Imiquimod—skin cancer	0.0026	0.00336	CcSEcCtD
Testosterone Propionate—Nausea—Vismodegib—skin cancer	0.00258	0.00334	CcSEcCtD
Testosterone Propionate—Gastrointestinal haemorrhage—Fluorouracil—skin cancer	0.00257	0.00332	CcSEcCtD
Testosterone Propionate—Malaise—Imiquimod—skin cancer	0.00253	0.00327	CcSEcCtD
Testosterone Propionate—Breast disorder—Temozolomide—skin cancer	0.00252	0.00326	CcSEcCtD
Testosterone Propionate—Irritability—Fluorouracil—skin cancer	0.00246	0.00317	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.00245	0.00316	CcSEcCtD
Testosterone Propionate—Haematuria—Bleomycin—skin cancer	0.00243	0.00314	CcSEcCtD
Testosterone Propionate—Hypertension—Imiquimod—skin cancer	0.00242	0.00313	CcSEcCtD
Testosterone Propionate—Myalgia—Imiquimod—skin cancer	0.00239	0.00309	CcSEcCtD
Testosterone Propionate—Arthralgia—Imiquimod—skin cancer	0.00239	0.00309	CcSEcCtD
Testosterone Propionate—Anxiety—Imiquimod—skin cancer	0.00238	0.00308	CcSEcCtD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.00237	0.00307	CcSEcCtD
Testosterone Propionate—AR—lymph node—skin cancer	0.00237	0.0105	CbGeAlD
Testosterone Propionate—Discomfort—Imiquimod—skin cancer	0.00236	0.00305	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Vemurafenib—skin cancer	0.00232	0.003	CcSEcCtD
Testosterone Propionate—Fatigue—Vemurafenib—skin cancer	0.00231	0.00299	CcSEcCtD
Testosterone Propionate—Neoplasm—Docetaxel—skin cancer	0.00231	0.00299	CcSEcCtD
Testosterone Propionate—Haemoglobin—Bleomycin—skin cancer	0.0023	0.00297	CcSEcCtD
Testosterone Propionate—Oedema—Imiquimod—skin cancer	0.00229	0.00296	CcSEcCtD
Testosterone Propionate—Haemorrhage—Bleomycin—skin cancer	0.00229	0.00296	CcSEcCtD
Testosterone Propionate—Dysuria—Temozolomide—skin cancer	0.00226	0.00292	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Imiquimod—skin cancer	0.00225	0.0029	CcSEcCtD
Testosterone Propionate—Skin disorder—Imiquimod—skin cancer	0.00222	0.00287	CcSEcCtD
Testosterone Propionate—Erectile dysfunction—Temozolomide—skin cancer	0.00222	0.00287	CcSEcCtD
Testosterone Propionate—Weight increased—Temozolomide—skin cancer	0.0022	0.00284	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Imiquimod—skin cancer	0.00209	0.0027	CcSEcCtD
Testosterone Propionate—Insomnia—Imiquimod—skin cancer	0.00207	0.00268	CcSEcCtD
Testosterone Propionate—Paraesthesia—Imiquimod—skin cancer	0.00206	0.00266	CcSEcCtD
Testosterone Propionate—Dyspnoea—Imiquimod—skin cancer	0.00204	0.00264	CcSEcCtD
Testosterone Propionate—Hepatobiliary disease—Temozolomide—skin cancer	0.00203	0.00263	CcSEcCtD
Testosterone Propionate—Alopecia—Bleomycin—skin cancer	0.00202	0.00261	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Vemurafenib—skin cancer	0.00198	0.00256	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Imiquimod—skin cancer	0.00198	0.00255	CcSEcCtD
Testosterone Propionate—Fatigue—Imiquimod—skin cancer	0.00197	0.00255	CcSEcCtD
Testosterone Propionate—Pain—Imiquimod—skin cancer	0.00196	0.00253	CcSEcCtD
Testosterone Propionate—Dermatitis bullous—Docetaxel—skin cancer	0.00194	0.00251	CcSEcCtD
Testosterone Propionate—Haemoglobin—Temozolomide—skin cancer	0.00194	0.00251	CcSEcCtD
Testosterone Propionate—Haemorrhage—Temozolomide—skin cancer	0.00193	0.0025	CcSEcCtD
Testosterone Propionate—Asthenia—Vemurafenib—skin cancer	0.00193	0.00249	CcSEcCtD
Testosterone Propionate—Urinary tract disorder—Temozolomide—skin cancer	0.00191	0.00247	CcSEcCtD
Testosterone Propionate—Pruritus—Vemurafenib—skin cancer	0.0019	0.00246	CcSEcCtD
Testosterone Propionate—Connective tissue disorder—Temozolomide—skin cancer	0.0019	0.00245	CcSEcCtD
Testosterone Propionate—Urethral disorder—Temozolomide—skin cancer	0.00189	0.00245	CcSEcCtD
Testosterone Propionate—Alopecia—Dactinomycin—skin cancer	0.00189	0.00244	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Imiquimod—skin cancer	0.00189	0.00244	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Imiquimod—skin cancer	0.00187	0.00242	CcSEcCtD
Testosterone Propionate—Gastrointestinal haemorrhage—Docetaxel—skin cancer	0.00186	0.0024	CcSEcCtD
Testosterone Propionate—Ill-defined disorder—Bleomycin—skin cancer	0.00185	0.00239	CcSEcCtD
Testosterone Propionate—Diarrhoea—Vemurafenib—skin cancer	0.00184	0.00237	CcSEcCtD
Testosterone Propionate—Urticaria—Imiquimod—skin cancer	0.00182	0.00235	CcSEcCtD
Testosterone Propionate—Abdominal pain—Imiquimod—skin cancer	0.00181	0.00234	CcSEcCtD
Testosterone Propionate—Malaise—Bleomycin—skin cancer	0.0018	0.00232	CcSEcCtD
Testosterone Propionate—Haemoglobin—Fluorouracil—skin cancer	0.00179	0.00231	CcSEcCtD
Testosterone Propionate—Haemorrhage—Fluorouracil—skin cancer	0.00178	0.0023	CcSEcCtD
Testosterone Propionate—Dizziness—Vemurafenib—skin cancer	0.00178	0.00229	CcSEcCtD
Testosterone Propionate—Angiopathy—Temozolomide—skin cancer	0.00175	0.00226	CcSEcCtD
Testosterone Propionate—Immune system disorder—Temozolomide—skin cancer	0.00174	0.00225	CcSEcCtD
Testosterone Propionate—Mediastinal disorder—Temozolomide—skin cancer	0.00174	0.00225	CcSEcCtD
Testosterone Propionate—Ill-defined disorder—Dactinomycin—skin cancer	0.00172	0.00223	CcSEcCtD
Testosterone Propionate—Liver function test abnormal—Docetaxel—skin cancer	0.00171	0.00222	CcSEcCtD
Testosterone Propionate—Vomiting—Vemurafenib—skin cancer	0.00171	0.00221	CcSEcCtD
Testosterone Propionate—Alopecia—Temozolomide—skin cancer	0.00171	0.00221	CcSEcCtD
Testosterone Propionate—Myalgia—Bleomycin—skin cancer	0.0017	0.00219	CcSEcCtD
Testosterone Propionate—Rash—Vemurafenib—skin cancer	0.00169	0.00219	CcSEcCtD
Testosterone Propionate—Mental disorder—Temozolomide—skin cancer	0.00169	0.00219	CcSEcCtD
Testosterone Propionate—Dermatitis—Vemurafenib—skin cancer	0.00169	0.00219	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Imiquimod—skin cancer	0.00169	0.00218	CcSEcCtD
Testosterone Propionate—Headache—Vemurafenib—skin cancer	0.00168	0.00217	CcSEcCtD
Testosterone Propionate—Malnutrition—Temozolomide—skin cancer	0.00168	0.00217	CcSEcCtD
Testosterone Propionate—Breast disorder—Docetaxel—skin cancer	0.00168	0.00217	CcSEcCtD
Testosterone Propionate—Discomfort—Bleomycin—skin cancer	0.00168	0.00217	CcSEcCtD
Testosterone Propionate—Malaise—Dactinomycin—skin cancer	0.00168	0.00217	CcSEcCtD
Testosterone Propionate—Asthenia—Imiquimod—skin cancer	0.00164	0.00212	CcSEcCtD
Testosterone Propionate—Confusional state—Bleomycin—skin cancer	0.00164	0.00212	CcSEcCtD
Testosterone Propionate—Oedema—Bleomycin—skin cancer	0.00163	0.0021	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Bleomycin—skin cancer	0.00163	0.0021	CcSEcCtD
Testosterone Propionate—Pruritus—Imiquimod—skin cancer	0.00162	0.00209	CcSEcCtD
Testosterone Propionate—Nausea—Vemurafenib—skin cancer	0.00159	0.00206	CcSEcCtD
Testosterone Propionate—Myalgia—Dactinomycin—skin cancer	0.00158	0.00205	CcSEcCtD
Testosterone Propionate—Alopecia—Fluorouracil—skin cancer	0.00157	0.00203	CcSEcCtD
Testosterone Propionate—Diarrhoea—Imiquimod—skin cancer	0.00157	0.00202	CcSEcCtD
Testosterone Propionate—Discomfort—Dactinomycin—skin cancer	0.00156	0.00202	CcSEcCtD
Testosterone Propionate—Ill-defined disorder—Temozolomide—skin cancer	0.00156	0.00202	CcSEcCtD
Testosterone Propionate—Oedema—Dactinomycin—skin cancer	0.00152	0.00196	CcSEcCtD
Testosterone Propionate—Malaise—Temozolomide—skin cancer	0.00152	0.00196	CcSEcCtD
Testosterone Propionate—Dizziness—Imiquimod—skin cancer	0.00151	0.00196	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Bleomycin—skin cancer	0.00148	0.00192	CcSEcCtD
Testosterone Propionate—Paraesthesia—Bleomycin—skin cancer	0.00146	0.00189	CcSEcCtD
Testosterone Propionate—Weight increased—Docetaxel—skin cancer	0.00146	0.00189	CcSEcCtD
Testosterone Propionate—Vomiting—Imiquimod—skin cancer	0.00146	0.00188	CcSEcCtD
Testosterone Propionate—Hypertension—Temozolomide—skin cancer	0.00145	0.00188	CcSEcCtD
Testosterone Propionate—Dyspnoea—Bleomycin—skin cancer	0.00145	0.00187	CcSEcCtD
Testosterone Propionate—Rash—Imiquimod—skin cancer	0.00144	0.00187	CcSEcCtD
Testosterone Propionate—Dermatitis—Imiquimod—skin cancer	0.00144	0.00186	CcSEcCtD
Testosterone Propionate—Headache—Imiquimod—skin cancer	0.00143	0.00185	CcSEcCtD
Testosterone Propionate—Arthralgia—Temozolomide—skin cancer	0.00143	0.00185	CcSEcCtD
Testosterone Propionate—Myalgia—Temozolomide—skin cancer	0.00143	0.00185	CcSEcCtD
Testosterone Propionate—Anxiety—Temozolomide—skin cancer	0.00143	0.00184	CcSEcCtD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.00142	0.00184	CcSEcCtD
Testosterone Propionate—Discomfort—Temozolomide—skin cancer	0.00141	0.00183	CcSEcCtD
Testosterone Propionate—Pain—Bleomycin—skin cancer	0.00139	0.0018	CcSEcCtD
Testosterone Propionate—Confusional state—Temozolomide—skin cancer	0.00138	0.00179	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.00138	0.00179	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Temozolomide—skin cancer	0.00137	0.00177	CcSEcCtD
Testosterone Propionate—Oedema—Temozolomide—skin cancer	0.00137	0.00177	CcSEcCtD
Testosterone Propionate—Nausea—Imiquimod—skin cancer	0.00136	0.00176	CcSEcCtD
Testosterone Propionate—Hepatobiliary disease—Docetaxel—skin cancer	0.00135	0.00175	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Temozolomide—skin cancer	0.00135	0.00174	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Bleomycin—skin cancer	0.00134	0.00173	CcSEcCtD
Testosterone Propionate—Skin disorder—Temozolomide—skin cancer	0.00133	0.00172	CcSEcCtD
Testosterone Propionate—Myalgia—Fluorouracil—skin cancer	0.00132	0.0017	CcSEcCtD
Testosterone Propionate—Fatigue—Dactinomycin—skin cancer	0.00131	0.00169	CcSEcCtD
Testosterone Propionate—Discomfort—Fluorouracil—skin cancer	0.0013	0.00168	CcSEcCtD
Testosterone Propionate—Pain—Dactinomycin—skin cancer	0.0013	0.00168	CcSEcCtD
Testosterone Propionate—Urticaria—Bleomycin—skin cancer	0.00129	0.00167	CcSEcCtD
Testosterone Propionate—Haemoglobin—Docetaxel—skin cancer	0.00129	0.00167	CcSEcCtD
Testosterone Propionate—Haemorrhage—Docetaxel—skin cancer	0.00128	0.00166	CcSEcCtD
Testosterone Propionate—Confusional state—Fluorouracil—skin cancer	0.00127	0.00165	CcSEcCtD
Testosterone Propionate—Urinary tract disorder—Docetaxel—skin cancer	0.00127	0.00164	CcSEcCtD
Testosterone Propionate—Oedema—Fluorouracil—skin cancer	0.00126	0.00163	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Fluorouracil—skin cancer	0.00126	0.00163	CcSEcCtD
Testosterone Propionate—Connective tissue disorder—Docetaxel—skin cancer	0.00126	0.00163	CcSEcCtD
Testosterone Propionate—Urethral disorder—Docetaxel—skin cancer	0.00126	0.00163	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Dactinomycin—skin cancer	0.00125	0.00162	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Temozolomide—skin cancer	0.00125	0.00162	CcSEcCtD
Testosterone Propionate—Insomnia—Temozolomide—skin cancer	0.00124	0.0016	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Dactinomycin—skin cancer	0.00124	0.0016	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Fluorouracil—skin cancer	0.00124	0.0016	CcSEcCtD
Testosterone Propionate—Paraesthesia—Temozolomide—skin cancer	0.00123	0.00159	CcSEcCtD
Testosterone Propionate—Dyspnoea—Temozolomide—skin cancer	0.00122	0.00158	CcSEcCtD
Testosterone Propionate—Abdominal pain—Dactinomycin—skin cancer	0.0012	0.00155	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Bleomycin—skin cancer	0.0012	0.00155	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Temozolomide—skin cancer	0.00118	0.00153	CcSEcCtD
Testosterone Propionate—Fatigue—Temozolomide—skin cancer	0.00118	0.00153	CcSEcCtD
Testosterone Propionate—Pain—Temozolomide—skin cancer	0.00117	0.00152	CcSEcCtD
Testosterone Propionate—Asthenia—Bleomycin—skin cancer	0.00117	0.00151	CcSEcCtD
Testosterone Propionate—Angiopathy—Docetaxel—skin cancer	0.00117	0.00151	CcSEcCtD
Testosterone Propionate—Immune system disorder—Docetaxel—skin cancer	0.00116	0.0015	CcSEcCtD
Testosterone Propionate—Mediastinal disorder—Docetaxel—skin cancer	0.00116	0.0015	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.00115	0.00149	CcSEcCtD
Testosterone Propionate—Pruritus—Bleomycin—skin cancer	0.00115	0.00149	CcSEcCtD
Testosterone Propionate—Insomnia—Fluorouracil—skin cancer	0.00114	0.00148	CcSEcCtD
Testosterone Propionate—Paraesthesia—Fluorouracil—skin cancer	0.00114	0.00147	CcSEcCtD
Testosterone Propionate—Alopecia—Docetaxel—skin cancer	0.00114	0.00147	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Temozolomide—skin cancer	0.00113	0.00146	CcSEcCtD
Testosterone Propionate—Dyspnoea—Fluorouracil—skin cancer	0.00113	0.00146	CcSEcCtD
Testosterone Propionate—Mental disorder—Docetaxel—skin cancer	0.00113	0.00145	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Temozolomide—skin cancer	0.00112	0.00145	CcSEcCtD
Testosterone Propionate—Malnutrition—Docetaxel—skin cancer	0.00112	0.00145	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Dactinomycin—skin cancer	0.00112	0.00144	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Fluorouracil—skin cancer	0.00109	0.00141	CcSEcCtD
Testosterone Propionate—Urticaria—Temozolomide—skin cancer	0.00109	0.00141	CcSEcCtD
Testosterone Propionate—Asthenia—Dactinomycin—skin cancer	0.00109	0.00141	CcSEcCtD
Testosterone Propionate—Abdominal pain—Temozolomide—skin cancer	0.00108	0.0014	CcSEcCtD
Testosterone Propionate—Pain—Fluorouracil—skin cancer	0.00108	0.0014	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Fluorouracil—skin cancer	0.00104	0.00135	CcSEcCtD
Testosterone Propionate—Diarrhoea—Dactinomycin—skin cancer	0.00104	0.00134	CcSEcCtD
Testosterone Propionate—Vomiting—Bleomycin—skin cancer	0.00103	0.00134	CcSEcCtD
Testosterone Propionate—Rash—Bleomycin—skin cancer	0.00103	0.00133	CcSEcCtD
Testosterone Propionate—Dermatitis—Bleomycin—skin cancer	0.00102	0.00132	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Temozolomide—skin cancer	0.00101	0.00131	CcSEcCtD
Testosterone Propionate—Urticaria—Fluorouracil—skin cancer	0.001	0.0013	CcSEcCtD
Testosterone Propionate—Asthenia—Temozolomide—skin cancer	0.000985	0.00127	CcSEcCtD
Testosterone Propionate—Pruritus—Temozolomide—skin cancer	0.000971	0.00125	CcSEcCtD
Testosterone Propionate—Nausea—Bleomycin—skin cancer	0.000966	0.00125	CcSEcCtD
Testosterone Propionate—Hypertension—Docetaxel—skin cancer	0.000965	0.00125	CcSEcCtD
Testosterone Propionate—Vomiting—Dactinomycin—skin cancer	0.000965	0.00125	CcSEcCtD
Testosterone Propionate—Rash—Dactinomycin—skin cancer	0.000957	0.00124	CcSEcCtD
Testosterone Propionate—Arthralgia—Docetaxel—skin cancer	0.000952	0.00123	CcSEcCtD
Testosterone Propionate—Myalgia—Docetaxel—skin cancer	0.000952	0.00123	CcSEcCtD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000945	0.00122	CcSEcCtD
Testosterone Propionate—Diarrhoea—Temozolomide—skin cancer	0.000939	0.00121	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Fluorouracil—skin cancer	0.000932	0.0012	CcSEcCtD
Testosterone Propionate—Confusional state—Docetaxel—skin cancer	0.00092	0.00119	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Docetaxel—skin cancer	0.000913	0.00118	CcSEcCtD
Testosterone Propionate—Oedema—Docetaxel—skin cancer	0.000913	0.00118	CcSEcCtD
Testosterone Propionate—Dizziness—Temozolomide—skin cancer	0.000907	0.00117	CcSEcCtD
Testosterone Propionate—Nausea—Dactinomycin—skin cancer	0.000901	0.00116	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Docetaxel—skin cancer	0.000895	0.00116	CcSEcCtD
Testosterone Propionate—Pruritus—Fluorouracil—skin cancer	0.000895	0.00116	CcSEcCtD
Testosterone Propionate—Skin disorder—Docetaxel—skin cancer	0.000886	0.00115	CcSEcCtD
Testosterone Propionate—Vomiting—Temozolomide—skin cancer	0.000872	0.00113	CcSEcCtD
Testosterone Propionate—Rash—Temozolomide—skin cancer	0.000865	0.00112	CcSEcCtD
Testosterone Propionate—Diarrhoea—Fluorouracil—skin cancer	0.000865	0.00112	CcSEcCtD
Testosterone Propionate—Dermatitis—Temozolomide—skin cancer	0.000864	0.00112	CcSEcCtD
Testosterone Propionate—Headache—Temozolomide—skin cancer	0.00086	0.00111	CcSEcCtD
Testosterone Propionate—Dizziness—Fluorouracil—skin cancer	0.000836	0.00108	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000831	0.00107	CcSEcCtD
Testosterone Propionate—Insomnia—Docetaxel—skin cancer	0.000825	0.00107	CcSEcCtD
Testosterone Propionate—Paraesthesia—Docetaxel—skin cancer	0.000819	0.00106	CcSEcCtD
Testosterone Propionate—Nausea—Temozolomide—skin cancer	0.000815	0.00105	CcSEcCtD
Testosterone Propionate—Dyspnoea—Docetaxel—skin cancer	0.000814	0.00105	CcSEcCtD
Testosterone Propionate—Vomiting—Fluorouracil—skin cancer	0.000804	0.00104	CcSEcCtD
Testosterone Propionate—Rash—Fluorouracil—skin cancer	0.000797	0.00103	CcSEcCtD
Testosterone Propionate—Dermatitis—Fluorouracil—skin cancer	0.000796	0.00103	CcSEcCtD
Testosterone Propionate—Headache—Fluorouracil—skin cancer	0.000792	0.00102	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Docetaxel—skin cancer	0.000788	0.00102	CcSEcCtD
Testosterone Propionate—Fatigue—Docetaxel—skin cancer	0.000787	0.00102	CcSEcCtD
Testosterone Propionate—Pain—Docetaxel—skin cancer	0.00078	0.00101	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Docetaxel—skin cancer	0.000752	0.000972	CcSEcCtD
Testosterone Propionate—Nausea—Fluorouracil—skin cancer	0.000751	0.000971	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Docetaxel—skin cancer	0.000746	0.000964	CcSEcCtD
Testosterone Propionate—Abdominal pain—Docetaxel—skin cancer	0.000721	0.000932	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Docetaxel—skin cancer	0.000672	0.000869	CcSEcCtD
Testosterone Propionate—Asthenia—Docetaxel—skin cancer	0.000655	0.000846	CcSEcCtD
Testosterone Propionate—Pruritus—Docetaxel—skin cancer	0.000646	0.000834	CcSEcCtD
Testosterone Propionate—Diarrhoea—Docetaxel—skin cancer	0.000624	0.000807	CcSEcCtD
Testosterone Propionate—Dizziness—Docetaxel—skin cancer	0.000603	0.00078	CcSEcCtD
Testosterone Propionate—Vomiting—Docetaxel—skin cancer	0.00058	0.00075	CcSEcCtD
Testosterone Propionate—Rash—Docetaxel—skin cancer	0.000575	0.000744	CcSEcCtD
Testosterone Propionate—Dermatitis—Docetaxel—skin cancer	0.000575	0.000743	CcSEcCtD
Testosterone Propionate—Headache—Docetaxel—skin cancer	0.000572	0.000739	CcSEcCtD
Testosterone Propionate—Nausea—Docetaxel—skin cancer	0.000542	0.000701	CcSEcCtD
